Dr. Reddy’s Laboratories re-launched Esomeprazole Magnesium Delayed-Release capsules in the U.S. market after changing the capsule’s colour.
The drug, indicated for treatment of acid reflux, is a therapeutic equivalent generic version of Astrazeneca’s Nexium.
Background
The company had launched the generic version of Nexium in September, following the USFDA approval. It, however, was restrained in November by a U.S. court from selling the product after Astrazeneca objected to the use of the colour Purple for the generic product. The temporary restraining order was passed pending further hearing or trial, Dr.Reddy’s had said.
Fact Punch
At the time of the launch in September, the company citing the IMS Health figures said that the sales of both branded and generic Nexium in the U.S. market during the 12 months ended July was $5.2 billion.
The product was expected to contribute around $30 million to $50 million in sales to Dr.Reddy’s.
Current Affairs: 30th December, 2015 Important Days in November and December Current Affairs bullet points Round up 15th to 21st December, 2015 Current Affairs Round up November, 2015.
Join The Discussion